T‐cell receptor–like chimeric antigen receptor T cells targeting mesothelin: A first‐in‐human dose‐escalation trial for platinum‐resistant advanced ovarian cancer.
Saved in:
| Title: | T‐cell receptor–like chimeric antigen receptor T cells targeting mesothelin: A first‐in‐human dose‐escalation trial for platinum‐resistant advanced ovarian cancer. |
|---|---|
| Authors: | Shan, Yiyang1 (AUTHOR), Ding, Bo1,2 (AUTHOR), Ji, Feng2,3 (AUTHOR), Lin, Hao1,2,3 (AUTHOR), Shi, Weiwei1,2 (AUTHOR), Wang, Enxiu4,5,6,7 (AUTHOR), Wang, Chen4 (AUTHOR), Shen, Yang1,2 (AUTHOR) shenyang@seu.edu.cn |
| Source: | Cancer (0008543X). Feb2026, Vol. 132 Issue 3, p1-13. 13p. |
| Database: | Academic Search Ultimate |
| ISSN: | 0008543X |
|---|---|
| DOI: | 10.1002/cncr.70279 |
